MeSH Review:
Lymphoma, Mantle-Cell
Andersen,
Larsen,
Christiansen,
Pedersen,
Christophersen,
Geisler,
Jurlander,
Fu,
Weisenburger,
Greiner,
Dave,
Wright,
Rosenwald,
Chiorazzi,
Iqbal,
Gesk,
Siebert,
De Jong,
Jaffe,
Wilson,
Delabie,
Ott,
Dave,
Sanger,
Smith,
Rimsza,
Braziel,
Müller-Hermelink,
Campo,
Gascoyne,
Staudt,
Chan,
Corcione,
Arduino,
Ferretti,
Raffaghello,
Roncella,
Rossi,
Fedeli,
Ottonello,
Trentin,
Dallegri,
Semenzato,
Pistoia,
Rummel,
Chow,
Jäger,
Hossfeld,
Bergmann,
Peters,
Hansmann,
Meyer,
Hoelzer,
Mitrou,
Kouroukis,
Belch,
Crump,
Eisenhauer,
Gascoyne,
Meyer,
Lohmann,
Lopez,
Powers,
Turner,
Connors,
Goy,
Remache,
Gu,
Stewart,
Hayes,
Gold,
Jiang,
Barkoh,
Katz,
Cabanillas,
Gilles,
Morris,
Thomson,
Craddock,
Mahendra,
Milligan,
Cook,
Smith,
Parker,
Schey,
Chopra,
Hatton,
Tighe,
Hunter,
Peggs,
Linch,
Goldstone,
Mackinnon,
- The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. Trentin, L., Agostini, C., Facco, M., Piazza, F., Perin, A., Siviero, M., Gurrieri, C., Galvan, S., Adami, F., Zambello, R., Semenzato, G. J. Clin. Invest. (1999)
- Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. Hochhauser, D., Schnieders, B., Ercikan-Abali, E., Gorlick, R., Muise-Helmericks, R., Li, W.W., Fan, J., Banerjee, D., Bertino, J.R. J. Natl. Cancer Inst. (1996)
- Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Morris, E., Thomson, K., Craddock, C., Mahendra, P., Milligan, D., Cook, G., Smith, G.M., Parker, A., Schey, S., Chopra, R., Hatton, C., Tighe, J., Hunter, A., Peggs, K., Linch, D., Goldstone, A., Mackinnon, S. Blood (2004)
- Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Mikaelsson, E., Danesh-Manesh, A.H., Lüppert, A., Jeddi-Tehrani, M., Rezvany, M.R., Sharifian, R.A., Safaie, R., Roohi, A., Osterborg, A., Shokri, F., Mellstedt, H., Rabbani, H. Blood (2005)
- PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M.A., Villamor, N., Tassies, D., Jaffe, E.S., Montserrat, E., Rozman, C. Blood (1994)
- Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'étude des Lymphomes Digestifs. Ruskoné-Fourmestraux, A., Delmer, A., Lavergne, A., Molina, T., Brousse, N., Audouin, J., Rambaud, J.C. Gastroenterology (1997)
- Expression of the mucosal homing receptor alpha 4 beta 7 in malignant lymphomatous polyposis of the intestine. Pals, S.T., Drillenburg, P., Dragosics, B., Lazarovits, A.I., Radaszkiewicz, T. Gastroenterology (1994)
- Mantle cell lymphoma is characterized by inactivation of the ATM gene. Schaffner, C., Idler, I., Stilgenbauer, S., Döhner, H., Lichter, P. Proc. Natl. Acad. Sci. U.S.A. (2000)
- The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Pérez-Galán, P., Roué, G., Villamor, N., Montserrat, E., Campo, E., Colomer, D. Blood (2006)
- The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Katzenberger, T., Petzoldt, C., Höller, S., Mäder, U., Kalla, J., Adam, P., Ott, M.M., Müller-Hermelink, H.K., Rosenwald, A., Ott, G. Blood (2006)
- Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma. Kaufmann, H., Raderer, M., Wöhrer, S., Püspök, A., Bankier, A., Zielinski, C., Chott, A., Drach, J. Blood (2004)
- Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures. Andersen, N.S., Larsen, J.K., Christiansen, J., Pedersen, L.B., Christophersen, N.S., Geisler, C.H., Jurlander, J. Blood (2000)
- Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma. Zinzani, P.L., Magagnoli, M., Moretti, L., De Renzo, A., Battista, R., Zaccaria, A., Guardigni, L., Mazza, P., Marra, R., Ronconi, F., Lauta, V.M., Bendandi, M., Gherlinzoni, F., Gentilini, P., Ciccone, F., Cellini, C., Stefoni, V., Ricciuti, F., Gobbi, M., Tura, S. J. Clin. Oncol. (2000)
- Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group. Kouroukis, C.T., Belch, A., Crump, M., Eisenhauer, E., Gascoyne, R.D., Meyer, R., Lohmann, R., Lopez, P., Powers, J., Turner, R., Connors, J.M. J. Clin. Oncol. (2003)
- Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival. Howard, O.M., Gribben, J.G., Neuberg, D.S., Grossbard, M., Poor, C., Janicek, M.J., Shipp, M.A. J. Clin. Oncol. (2002)
- Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Stilgenbauer, S., Liebisch, P., James, M.R., Schröder, M., Schlegelberger, B., Fischer, K., Bentz, M., Lichter, P., Döhner, H. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Fu, K., Weisenburger, D.D., Greiner, T.C., Dave, S., Wright, G., Rosenwald, A., Chiorazzi, M., Iqbal, J., Gesk, S., Siebert, R., De Jong, D., Jaffe, E.S., Wilson, W.H., Delabie, J., Ott, G., Dave, B.J., Sanger, W.G., Smith, L.M., Rimsza, L., Braziel, R.M., Müller-Hermelink, H.K., Campo, E., Gascoyne, R.D., Staudt, L.M., Chan, W.C. Blood (2005)
- p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Greiner, T.C., Moynihan, M.J., Chan, W.C., Lytle, D.M., Pedersen, A., Anderson, J.R., Weisenburger, D.D. Blood (1996)
- Correspondence re: S. Beá et al., BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res., 61: 2409-2412, 2001. Raaphorst, F.M., Meijer, C.J., Otte, A.P. Cancer Res. (2002)
- Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas. Aguilera, N.S., Bijwaard, K.E., Duncan, B., Krafft, A.E., Chu, W.S., Abbondanzo, S.L., Lichy, J.H., Taubenberger, J.K. Am. J. Pathol. (1998)
- How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques. Pittaluga, S., Tierens, A., Dodoo, Y.L., Delabie, J., De Wolf-Peeters, C. Am. J. Clin. Pathol. (1999)
- Improved detection of CD5 epitope in formalin-fixed paraffin-embedded sections of benign and neoplastic lymphoid tissues by using biotinylated tyramine enhancement after antigen retrieval. Butmarc, J.R., Kourea, H.P., Levi, E., Kadin, M.E. Am. J. Clin. Pathol. (1998)
- Composite Hodgkin lymphoma and mantle cell lymphoma: two clonally unrelated tumors. Caleo, A., Sánchez-Aguilera, A., Rodríguez, S., Dotor, A.M., Beltrán, L., de Larrinoa, A.F., Menárguez, F.J., Piris, M.A., García, J.F. Am. J. Surg. Pathol. (2003)
- Establishment and characterization of a new mantle cell lymphoma cell line M-1. Goy, A., Remache, Y.K., Gu, J., Stewart, J., Hayes, K.J., Gold, D., Jiang, Y., Barkoh, B.A., Katz, R., Cabanillas, F., Gilles, F. Leuk. Lymphoma (2004)
- Acute interstitial nephritis with polyclonal B cell infiltration and development of mantle cell lymphoma. Wu, Q., Jinde, K., Yanagi, H., Endoh, M., Sakai, H. Intern. Med. (2002)
- Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Stankovic, T., Stewart, G.S., Fegan, C., Biggs, P., Last, J., Byrd, P.J., Keenan, R.D., Moss, P.A., Taylor, A.M. Blood (2002)
- Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Chiarle, R., Budel, L.M., Skolnik, J., Frizzera, G., Chilosi, M., Corato, A., Pizzolo, G., Magidson, J., Montagnoli, A., Pagano, M., Maes, B., De Wolf-Peeters, C., Inghirami, G. Blood (2000)
- CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Hernández, L., Beà, S., Pinyol, M., Ott, G., Katzenberger, T., Rosenwald, A., Bosch, F., López-Guillermo, A., Delabie, J., Colomer, D., Montserrat, E., Campo, E. Cancer Res. (2005)
- CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells. Corcione, A., Arduino, N., Ferretti, E., Raffaghello, L., Roncella, S., Rossi, D., Fedeli, F., Ottonello, L., Trentin, L., Dallegri, F., Semenzato, G., Pistoia, V. Clin. Cancer Res. (2004)
- High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma. Islam, T.C., Asplund, A.C., Lindvall, J.M., Nygren, L., Liden, J., Kimby, E., Christensson, B., Smith, C.I., Sander, B. Leukemia (2003)
- Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies. Senderowicz, A.M. Leukemia (2001)
- Proliferative response of mantle cell lymphoma cells stimulated by CD40 ligation and IL-4. Castillo, R., Mascarenhas, J., Telford, W., Chadburn, A., Friedman, S.M., Schattner, E.J. Leukemia (2000)
- In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma. Williams, M.E., Nichols, G.E., Swerdlow, S.H., Stoler, M.H. Ann. Oncol. (1995)
- Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse. Rummel, M.J., Chow, K.U., Jäger, E., Hossfeld, D.K., Bergmann, L., Peters, H.D., Hansmann, M.L., Meyer, A., Hoelzer, D., Mitrou, P.S. Ann. Oncol. (1999)
